Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;17(3):537-44.
doi: 10.1110/ps.073163308. Epub 2008 Jan 24.

Conformational pH dependence of intermediate states during oligomerization of the human prion protein

Affiliations

Conformational pH dependence of intermediate states during oligomerization of the human prion protein

Remo Gerber et al. Protein Sci. 2008 Mar.

Abstract

Intermediate states are key to understanding the molecular mechanisms governing protein misfolding. The human prion protein (PrP) can follow various misfolding pathways, and forms a soluble beta-sheet-rich oligomer under acidic, mildly denaturing, high salt conditions. Here we describe a fast conformational switch from the native alpha-monomer to monomeric intermediate states under oligomer-forming conditions, followed by a slower oligomerization process. We observe a pH dependence of the secondary structure of these intermediate forms, with almost native-like alpha-helical secondary structure at pH 4.1 and predominantly beta-sheet characteristics at pH 3.6. NMR spectroscopy differentiates these intermediate states from the native protein and indicates dynamic rearrangements of secondary structure elements characteristic of a molten globule. The alpha-helical intermediate formed at pH 4.1 can convert to the beta-sheet conformation at pH 3.6 but not vice versa, and neither state can be reconverted to an alpha-monomer. The presence of methionine rather than valine at codon 129 accelerates the rate of oligomer formation from the intermediate state.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Misfolding model of human prion protein in vitro. In this schematic, the various in vitro folding pathways of recombinant, disulfide-oxidized PrP are summarized as discussed in the literature (Baskakov et al. 2001, 2002; Tahiri-Alaoui et al. 2006). It was recently shown that the intermediate state along pathway 1 is more populated during folding at low pH 4.8 in comparison to folding at pH 7.0 (Apetri et al. 2006). The shaded area of intermediate states during misfolding is of particular interest due to the unknown molecular mechanism governing and initiating prion misfolding. In this work we differentiate the intermediate folding landscape by showing the existence of α-helical and β-sheet-rich monomeric precursors αi and βi during misfolding along pathway 6. The effects on the folding kinetics are shown with respect to residue 129 of the common polymorphism encoding either methionine (M) or valine (V) or for their equimolar mixture (MV) (Tahiri-Alaoui et al. 2004, 2006; Baskakov et al. 2005; Tahiri-Alaoui and James 2005). Here we report an influence of codon 129 on pathway 6. The bold dotted lines indicate that the formation of β-oligomer proceeds through two different pathways that are most likely separated by a free energy barrier.
Figure 2.
Figure 2.
Identification of monomeric folding intermediates with either α-helical or β-sheet secondary structures depending on pH. (A,B) Oligomerization of PrP was monitored with far-UV CD at pH 4.1 and pH 3.6, respectively. While the spectra of αN and βO were recorded for the stable species, the evolving αi and βi were monitored at incubation times of 5, 45, 90, 180, and 240 min and 53 h, as indicated. (C) The sec-HPLC chromatograms for αN, βO, αi (dashed line) and βi (dotted-dashed line) eluting at 9.89, 6.58, 9.11, and 9.44 min are shown, respectively. The elution profiles of αN, αi, and βi are distinguishable by their elution times between 9 and 10 min.
Figure 3.
Figure 3.
Oligomerization intermediates have nonnative tertiary structure. (A–C) The 1H-15N HSQC spectra of αN, αi, and βi are shown, respectively. Resonances in A were assigned according to Hosszu et al. (2004), and peaks that are observed in all three spectra are marked with an asterisk. (B,C) The HSQC spectra of both αi and βi show about 60 sharp resonances, most of which fall within the random-coil region between 7.7 and 8.7 ppm 1H chemical shift. The loss of dispersed resonances is indicative of a nonnative molten globule conformation.
Figure 4.
Figure 4.
The intermediate states αi and βi cannot be reversed to α-monomer. (A) Native αN was converted to αi and then the pH was either dropped to pH 3.6 converting αi to βi or raised to pH 5.5. (B) Similar to A, αN was converted into βi, and subsequently, the pH was raised back to either pH 4.1 or pH 5.5. (C) The 1H-15N HSQC spectrum of βi after the pH had been shifted back to pH 5.5 shows a near complete loss of sharp resonances. (D) A schematic of the pathways accessible to αi and βi as probed with CD is shown.
Figure 5.
Figure 5.
The late stage of oligomerization on pathway 6 is affected by codon 129. Pathway 6 misfolding was monitored by injecting samples onto a sec-HPLC column at different incubation times under oligomer-favoring conditions. Oligomerization of Met129 (A,D), Val129 (B,E), and the equimolar mixture Met/Val129 (C,F) was monitored at both pH 4.1 (A–C) and pH 3.6 (D–E), respectively. The βM (multimer as described by Baskakov et al. [2001, 2002, 2005]) βO, αi, and βi fractions eluting at 5.0, 6.58, 9.44, and 9.11 min are indicated in the figure (A and D), respectively. (G,H) The non-monomeric fractions of 5.0–8.7 min of the elution profiles were integrated and mono-exponential association curves fitted to the points for Met129 (■), Val129 (▼), Met/Val129 (●), respectively. (I) The rate constants for Met129, Val129, and Met/Val129 indicate the most rapid oligomerization for Met129. The rates for pH 3.6 and pH 4.1 are within the same order but plateau levels are overall lower at pH 4.1.

Similar articles

Cited by

References

    1. Ahmad, A., Millett, I.S., Doniach, S., Uversky, V.N., Fink, A.L. Partially folded intermediates in insulin fibrillation. Biochemistry. 2003;42:11404–11416. - PubMed
    1. Apetri, A.C., Maki, K., Roder, H., Surewicz, W.K. Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J. Am. Chem. Soc. 2006;128:11673–11678. - PMC - PubMed
    1. Baskakov, I.V., Legname, G., Prusiner, S.B., Cohen, F.E. Folding of prion protein to its native α-helical conformation is under kinetic control. J. Biol. Chem. 2001;276:19687–19690. - PubMed
    1. Baskakov, I.V., Legname, G., Baldwin, M.A., Prusiner, S.B., Cohen, F.E. Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem. 2002;277:21140–21148. - PubMed
    1. Baskakov, I., Disterer, P., Breydo, L., Shaw, M., Gill, A., James, W., Tahiri-Alaoui, A. The presence of valine at residue 129 in human prion protein accelerates amyloid formation. FEBS Lett. 2005;579:2589–2596. - PubMed

Publication types

LinkOut - more resources